Dr. Virginia G. Kaklamani is a professor of medicine in the division of hematology/oncology at UT Health San Antonio and is the leader of the Breast Cancer Program at UT Health San Antonio MD Anderson Cancer Center.

Dr Virginia Kaklamani has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Virginia Kaklamani has received consulting fees for Menarini Stemline, Genetech, Lilly, Astrazeneca, Gilead, Novartis, Tersera, Daiichi, and is on the speakers’ bureau for Astrazeneca, Lilly, Novartis and Gilead. She has also received funding from Eisai